Reuters
Published November 16, 2026
Helus Pharma's psychedelic depression drug succeeds in late-stage study, shares jump
Read the full story at Reuters
J&J strikes $2.2 billion buyout deal for eye disease biotech Ollin Biosciences. 14 mins ago. China International Import Expo in Shanghai. Site Index.
Surfaced by 5 Google Alerts
- Psychedelic biotech
- Magic mushrooms
- Psychedelic crime
- Psychedelics asia
- Gray market psychedelics